2nd Patient to Get Foralumab Nasal Spray After Promising First Data
Following promising data from the first participant in a special access program that’s testingĀ foralumabĀ nasal spray forĀ secondary progressive multiple sclerosis (SPMS), a second patient has been enrolled in the ongoing evaluation. The first patient in the study, by Tiziana Life Sciences, the nasal spray’s developer, was halfway through…